News
Bayer HealthCare starts special lab space-model CoLaborator™ for promising life science companies
Bayer HealthCare officially opened its new life sciences hub for early stage research companies, dubbed the "CoLaborator™", in San Francisco's Mission Bay. The...
News
Double drug combo could shut down abnormal blood vessel growth
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch...
Clinical Trials
Hybrigenics starts phase II clinical trial of inecalcitol in chronic lymphocytic leukemia
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on research and development of new treatments against proliferative...
Press Releases
Dr. Reddy’s Announces the Launch of Metoprolol Succinate ER (Extended-Release) Tablets
Dr. Reddy’s Laboratories announced today that is has launched Metoprolol Succinate ER (Extended-Release) Tablets (25 mg, 50 mg, 100 mg & 200 mg),...
News
Large lung cancer study shows potential for more targeted therapies
A nationwide consortium of scientists has reported the first comprehensive genetic analysis of squamous cell carcinoma of the lung, a common type of...
Press Releases
Outcomes Measurement Leader launches QOLIX®, First-of-Its-Kind Quality of Life Measurement System
John Ware Research Group, Inc.,(JWRG), a leading health outcomes company, announces the launch of QOLIX, a patent pending Quality of Life Measurement Information...
News
Boehringer Ingelheim and the ETH Zurich announce diabetes and obesity research collaboration
Boehringer Ingelheim, the Institute of Molecular Health Science and the Institute of Food, Nutrition and Health of the ETH Zurich will collaborate to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read